Drug Information

General Information
Drug ID
DR00528
Drug Name
Propranolol
Synonyms
(+-)-Propranolol; (1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol; (R)-(+)-propranolol; (S)-(-)-PROPRANOLOL; 1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol; 1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane; 1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol; 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol; 1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol; 1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol; 1-Isopropylamino-3-(1-naphthyloxy)-2-propanol; 1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol; 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol; 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-(9CI); 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)-(9CI); 3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol; AY 64043; AY-20694; Anaprilin; Anapriline; Anaprilinum (TN); Avlocardyl; Avlocardyl (TN); Bedranol; Berkolol; Beta Neg; Beta-Propranolol; Beta-Tablinen; Beta-Timelets; Betachron; Betadren; Betalong; Caridolol; Corpendol; D,L-Propranolol; DL-Propranolol hydrochloride; Deralin (TN); Dociton; Dociton (TN); Efektolol;Etalong; Euprovasin; Herzbase; INDERIDE-40/25; INDERIDE-80/25; Ikopal; Inderal; Inderal (TN); Inderal LA (TN); Inderal hydrochloride; Inderalici; Inderalici (TN); Inderex; Inderol; InnoPran XL (TN); Intermigran; Kemi; Kemi S; Migrastat; Naprilin; Obsidan; Obzidan; Pranolol; Pronovan; Propanalol; Propanix; Propanolol; Propanolol [INN-Spanish]; Propranalol; Propranolol (INN); Propranolol (TN); Propranolol Hcl Intensol; Propranolol [INN:BAN]; Propranololo; Propranololo [DCIT]; Propranololum; Propranololum [INN-Latin]; Proprasylyt; R,S-Propranolol Hydrochloride; Racemic propranolol; Reducor; Reducorline; Sawatal; Servanolol; Sumial; Sumial (TN)
Drug Type
Small molecular drug
Indication High blood pressure [ICD11: BA00] Approved [1]
Migraine [ICD11: 8A80] Approved [1]
Therapeutic Class
Antianxiety Agents
Structure
3D MOL 2D MOL
Formula
C16H21NO2
Canonical SMILES
CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O
InChI
InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3/t14-/m1/s1
InChIKey
AQHHHDLHHXJYJD-CQSZACIVSA-N
CAS Number
CAS 525-66-6
Pharmaceutical Properties Molecular Weight 259.339 Topological Polar Surface Area 41.5
Heavy Atom Count 19 Rotatable Bond Count 6
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 3
XLogP
3
PubChem CID
21138
PubChem SID
103173037 , 104171303 , 104352460 , 11111608 , 11111609 , 11112324 , 11112325 , 11112326 , 11113604 , 11113728 , 11467103 , 11468223 , 11486731 , 124881054 , 124882253 , 124882254 , 127443802 , 13374 , 134984369 , 137003686 , 140305642 , 144203986 , 14774633 , 160966459 , 164820581 , 164824354 , 170464682 , 175269420 , 179230521 , 26744431 , 26751915 , 29288557 , 3248705 , 46504537 , 47589224 , 47736746 , 47885647 , 47885648 , 48185235 , 49699368 , 50023381 , 57330813 , 75285226 , 8165579 , 821435 , 85788116 , 89094304 , 93166288 , 96026375 , 99233252
ChEBI ID
ChEBI:8499
TTD Drug ID
D04JEE
DT(s) Transporting This Drug OCT-1 Transporter Info Organic cation transporter 1 Substrate [2]
OCT-2 Transporter Info Organic cation transporter 2 Substrate [2]
OCT-3 Transporter Info Organic cation transporter 3 Substrate [2]
P-GP Transporter Info P-glycoprotein 1 Substrate [3]
References
1 Propranolol was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Influx Transport of Cationic Drug at the Blood-Retinal Barrier: Impact on the Retinal Delivery of Neuroprotectants. Biol Pharm Bull. 2017;40(8):1139-1145.
3 Tarascon Pocket Pharmacopoeia 2018 Classic Shirt-Pocket Edition.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.